{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T03:14:45Z","timestamp":1778814885918,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2020-116076RJ-I00 \/AEI\/ 10.13039\/501100011033"],"award-info":[{"award-number":["PID2020-116076RJ-I00 \/AEI\/ 10.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006393","name":"Universidad de Granada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006393","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.bioorg.2025.108395","type":"journal-article","created":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T03:52:48Z","timestamp":1742615568000},"page":"108395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Exploring Trisubstituted adenine derivatives as adenosine A1 receptor ligands with antagonist activity: Synthesis, biological evaluation and molecular modelling"],"prefix":"10.1016","volume":"159","author":[{"given":"Laura B.","family":"C\u00f3rdoba-G\u00f3mez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1lvaro","family":"Lorente-Mac\u00edas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Isabel","family":"Loza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Brea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ant\u00f3n Leandro","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathon","family":"Mok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Franco-Montalban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio Gonz\u00e1lez","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Jos\u00e9","family":"Guardia-Monteagudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria J.","family":"Matos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asier","family":"Unciti-Broceta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Jos\u00e9","family":"D\u00edaz-Moch\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Jose Pineda de","family":"Las Infantas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bioorg.2025.108395_bb0005","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cbpa.2010.02.018","article-title":"Privileged scaffolds for library design and drug discovery","volume":"14","author":"Welsch","year":"2010","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"42","key":"10.1016\/j.bioorg.2025.108395_bb0010","doi-asserted-by":"crossref","first-page":"14629","DOI":"10.1021\/ja508343a","article-title":"Privileged structures: efficient chemical \u201cnavigators\u201d toward unexplored biologically relevant chemical spaces","volume":"136","author":"Kim","year":"2014","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108395_bb0015","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41392-021-00553-z","article-title":"From purines to purinergic signalling: molecular functions and human diseases","volume":"6","author":"Huang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108395_bb0020","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/1439-7633(20021004)3:10<928::AID-CBIC928>3.0.CO;2-5","article-title":"Drug design strategies for targeting G-protein-coupled receptors","volume":"3","author":"Klabunde","year":"2002","journal-title":"ChemBioChem"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108395_bb0025","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/S0022-3565(25)11442-0","article-title":"Evaluation of N-0861, (+\u2212)-N6-endonorbornan-2-yl-9-methyladenine, as an A1 subtype-selective adenosine receptor antagonist in the guinea pig isolated heart","volume":"260","author":"Shryock","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108395_bb0030","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2217\/14796678.4.2.117","article-title":"Rolofylline (KW-3902): a new adenosine A1-receptor antagonist for acute congestive heart failure","volume":"4","author":"Chaparro","year":"2008","journal-title":"Futur. Cardiol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108395_bb0035","doi-asserted-by":"crossref","DOI":"10.1007\/BF00165037","article-title":"Binding of the A1-selective adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine to rat brain membranes","volume":"335","author":"Bruns","year":"1987","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108395_bb0040","doi-asserted-by":"crossref","DOI":"10.1021\/jm0607956","article-title":"2,6,8-Trisubstituted 1-Deazapurines as adenosine receptor antagonists","volume":"50","author":"Chang","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108395_bb0045","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ejmech.2018.03.067","article-title":"New potent and selective A1 adenosine receptor antagonists as potential tools for the treatment of gastrointestinal diseases","volume":"151","author":"Lambertucci","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108395_bb0050","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/sj.bjp.0707319","article-title":"The adenosine A1 receptor antagonist SLV320 reduces myocardial fibrosis in rats with 5\/6 nephrectomy without affecting blood pressure","volume":"151","author":"Kalk","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"28","key":"10.1016\/j.bioorg.2025.108395_bb0055","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.2174\/0929867329666220218094501","article-title":"A 2A adenosine receptor antagonists and their potential in NeurologicalDisorders","volume":"29","author":"Lambertucci","year":"2022","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108395_bb0060","doi-asserted-by":"crossref","first-page":"9139","DOI":"10.1038\/srep09139","article-title":"Amide-controlled, one-pot synthesis of tri-substituted purines generates structural diversity and analogues with trypanocidal activity","volume":"5","author":"Pineda de las Infantas y Villatoro MJ","year":"2015","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108395_bb0065","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/mrc.4743","article-title":"1 H and 13 C assignments of 6-, 8-, 9- substituted purines","volume":"56","author":"Lorente-Mac\u00edas","year":"2018","journal-title":"Magn. Reson. Chem."},{"key":"10.1016\/j.bioorg.2025.108395_bb0070","article-title":"Design and synthesis of 9-Dialkylamino-6-[(1H-1,2,3-Triazol-4-Yl)Methoxy]-9H-purines","volume":"1","author":"Lorente-Mac\u00edas","year":"2021","journal-title":"ChemRxiv. Published online February"},{"key":"10.1016\/j.bioorg.2025.108395_bb0075","article-title":"Synthesis and screening of 6-alkoxy purine analogs as cell type-selective apoptotic inducers in Jurkat cells","volume":"354","author":"Lorente-Mac\u00edas","year":"2021","journal-title":"Arch Pharm Weinh."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108395_bb0080","doi-asserted-by":"crossref","first-page":"638","DOI":"10.3390\/ph14070638","article-title":"Novel purine Chemotypes with activity against plasmodium falciparum and Trypanosoma cruzi","volume":"14","author":"Martinez-Peinado","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2025.108395_bb0085","doi-asserted-by":"crossref","unstructured":"Gomez LC, Lorente-Macias A, Villatoro MJP de las I y, Garzon-Ruiz A, Diaz-Mochon JJ. Symmetric 4,6-Dialkyl\/arylamino-5-nitropyrimidines: Theoretical Explanation of Why Aminolysis of Alkoxy Groups Is Favoured over Chlorine Aminolysis in Nitro-Activated Pyrimidines. Published online May 4, 2023. doi:10.26434\/chemrxiv-2023-gkl0q.","DOI":"10.1039\/D3NJ03495J"},{"key":"10.1016\/j.bioorg.2025.108395_bb0090","first-page":"12","article-title":"Identification of compounds with activity against Trypanosoma cruzi within a collection of synthetic nucleoside analogs","author":"Barnadas-Carceller","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.bioorg.2025.108395_bb0095","article-title":"Role of A1 adenosine receptor in survival of human lung cancer","volume":"28","author":"Asgharkhah","year":"2022","journal-title":"Gene Rep."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108395_bb0100","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40425-018-0360-8","article-title":"Targeting adenosine for cancer immunotherapy","volume":"6","author":"Leone","year":"2018","journal-title":"J. Immunother. Cancer"},{"issue":"11","key":"10.1016\/j.bioorg.2025.108395_bb0105","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1139\/y92-205","article-title":"Effects of N6-endonorbornan-2-yl-9-methyladenine, N0861, on negative chronotropic and vasodilatory actions of adenosine in the canine heart in vivo","volume":"70","author":"Pelleg","year":"1992","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108395_bb0110","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.cell.2017.01.042","article-title":"Structure of the adenosine A1 receptor reveals the basis for subtype selectivity","volume":"168","author":"Glukhova","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2025.108395_bb0115","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41586-018-0236-6","article-title":"Structure of the adenosine-bound human adenosine Al receptor-Gi complex","volume":"558","author":"Draper-Joyce","year":"2018","journal-title":"Nature"},{"issue":"7877","key":"10.1016\/j.bioorg.2025.108395_bb0120","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/s41586-021-03897-2","article-title":"Positive allosteric mechanisms of adenosine A1 receptor-mediated analgesia","volume":"597","author":"Draper-Joyce","year":"2021","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.bioorg.2025.108395_bb0125","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.str.2017.06.012","article-title":"Structures of human a 1 and a 2A adenosine receptors with Xanthines reveal determinants of selectivity","volume":"25","author":"Cheng","year":"2017","journal-title":"Structure"},{"key":"10.1016\/j.bioorg.2025.108395_bb0130","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108395_bb0135","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108395_bb0140","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.bbamem.2010.12.017","article-title":"Recent developments in adenosine receptor ligands and their potential as novel drugs","volume":"1808","author":"M\u00fcller","year":"2011","journal-title":"Biochim. Biophys. Acta Biomembr."},{"issue":"23","key":"10.1016\/j.bioorg.2025.108395_bb0145","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108395_bb0150","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/0165-6147(93)90080-4","article-title":"Further concerns over Cheng-Prusoff analysis","volume":"14","author":"Leff","year":"1993","journal-title":"Trends Pharmacol. Sci."},{"issue":"16","key":"10.1016\/j.bioorg.2025.108395_bb0155","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108395_bb0160","first-page":"17","article-title":"Avogadro: an advanced semantic chemical editor, visualization, and analysis platform","volume":"4","author":"Hanwell","year":"2012","journal-title":"J. Chemother."},{"key":"10.1016\/j.bioorg.2025.108395_bb0165","series-title":"Gaussian 09 Revision A.1","author":"Frisch","year":"2009"},{"issue":"Web Server","key":"10.1016\/j.bioorg.2025.108395_bb0170","doi-asserted-by":"crossref","first-page":"W665","DOI":"10.1093\/nar\/gkh381","article-title":"PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations","volume":"32","author":"Dolinsky","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2025.108395_bb0175","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF chimera? A visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108395_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/PL00005131","article-title":"Comparative pharmacology of human adenosine receptor subtypes \u2013 characterization of stably transfected receptors in CHO cells","volume":"357","author":"Klotz","year":"1997","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108395_bb0185","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0031-6997(24)01511-4","article-title":"International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors","volume":"53","author":"Fredholm","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bioorg.2025.108395_bb0190","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0014-2999(02)01552-2","article-title":"2-Chloro-N6-cyclopentyladenosine, adenosine A1 receptor agonist, antagonizes the adenosine A3 receptor","volume":"443","author":"Gao","year":"2002","journal-title":"Eur. J. Pharmacol."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825002755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825002755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T22:26:12Z","timestamp":1778711172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825002755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":38,"alternative-id":["S0045206825002755"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108395","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring Trisubstituted adenine derivatives as adenosine A1 receptor ligands with antagonist activity: Synthesis, biological evaluation and molecular modelling","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108395","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108395"}}